127 related articles for article (PubMed ID: 9131725)
1. Roxindole, a dopamine autoreceptor agonist with a potential antidepressant activity. II. Effects on the 5-hydroxytryptamine system.
Maj J; Kołodziejczyk K; Rogóz Z; Skuza G
Pharmacopsychiatry; 1997 Mar; 30(2):55-61. PubMed ID: 9131725
[TBL] [Abstract][Full Text] [Related]
2. EMD 57445, the selective sigma receptor ligand, has no effect on the 5-hydroxytryptamine system.
Skuza G; Rogóz Z; Gołembiowska K
Pol J Pharmacol; 1997; 49(6):489-93. PubMed ID: 9566054
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological effects of oxaprotiline enantiomers on the central serotonin system.
Maj J; Dereń A; Moryl E
Pol J Pharmacol Pharm; 1989; 41(4):345-57. PubMed ID: 2534522
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes.
Czyrak A; Skuza G; Rogóz Z; Frankiewicz T; Maj J
Arzneimittelforschung; 1994 Feb; 44(2):113-8. PubMed ID: 7511901
[TBL] [Abstract][Full Text] [Related]
5. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
Scott PA; Chou JM; Tang H; Frazer A
J Pharmacol Exp Ther; 1994 Jul; 270(1):198-208. PubMed ID: 8035316
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of (+)WAY 100135 to behavioral, hypothermic and corticosterone effects induced by 8-OH-DPAT.
Przegaliński E; Filip M; Budziszewska B; Chojnacka-Wójcik E
Pol J Pharmacol; 1994; 46(1-2):21-7. PubMed ID: 7981767
[TBL] [Abstract][Full Text] [Related]
7. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
8. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A
Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
[TBL] [Abstract][Full Text] [Related]
10. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
Bartoszyk GD; Harting J; Minck KO
J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
[TBL] [Abstract][Full Text] [Related]
11. The effect of repeated treatment with oxaprotiline enantiomers on central 5-HT receptor subpopulations.
Dereń-Wesołek A; Maj J
Pol J Pharmacol; 1993; 45(2):133-50. PubMed ID: 8401766
[TBL] [Abstract][Full Text] [Related]
12. In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with\ increased motor disability.
Iravani MM; Tayarani-Binazir K; Chu WB; Jackson MJ; Jenner P
J Pharmacol Exp Ther; 2006 Dec; 319(3):1225-34. PubMed ID: 16959959
[TBL] [Abstract][Full Text] [Related]
13. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
[TBL] [Abstract][Full Text] [Related]
14. Involvement of dopamine autoreceptors in the hypoactivity induced by 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
Chojnacka-Wójcik E
Pol J Pharmacol Pharm; 1992; 44(2):135-46. PubMed ID: 1357637
[TBL] [Abstract][Full Text] [Related]
15. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
16. Roxindole, a potential antidepressant. I. Effect on the dopamine system.
Maj J; Kolodziejczyk K; Rogóz Z; Skuza G
J Neural Transm (Vienna); 1996; 103(5):627-41. PubMed ID: 8811507
[TBL] [Abstract][Full Text] [Related]
17. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181.
Hillegaart V; Ahlenius S
Br J Pharmacol; 1998 Dec; 125(8):1733-43. PubMed ID: 9886765
[TBL] [Abstract][Full Text] [Related]
18. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
[TBL] [Abstract][Full Text] [Related]
19. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.
Martínez-Mota L; Estrada-Camarena E; López-Rubalcava C
Psychopharmacology (Berl); 2002 Dec; 165(1):60-6. PubMed ID: 12474119
[TBL] [Abstract][Full Text] [Related]
20. Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications.
Ba M; Kong M; Ma G; Yang H; Lu G; Chen S; Liu Z
Brain Res; 2007 Jan; 1127(1):177-84. PubMed ID: 17113046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
